End-to-End High-Throughput Biotransformation Workflow: Automated Data Acquisition and Processing of Sub-Second UPLC Peaks Using Multi-Reflecting Time-of-Flight Mass Spectrometry and Dedicated Data-Mining Tools

Significance of the Topic

High-throughput, high-confidence identification of drug metabolites is critical in preclinical and clinical bioanalysis, toxicology, and drug discovery. Traditional UHPLC-HRMS workflows struggle to reconcile chromatographic speed, mass resolution, and data completeness: fast separations compress peaks, demanding higher MS acquisition rates and more sophisticated data processing to avoid loss of structural information. The workflow presented here addresses these constraints by combining sub-second UPLC separations with a multi-reflecting time-of-flight mass spectrometer and automated data-mining to deliver both throughput and structural confidence.

Objectives and Study Overview

The primary aim was to develop and validate an end-to-end, automated biotransformation workflow capable of (1) acquiring data from sub-second UPLC peaks without loss of MS/MS quality, (2) maintaining high mass accuracy and resolution, and (3) enabling automated metabolite identification with minimal manual intervention. The study used paracetamol (acetaminophen) dosing in beagle dogs as a test case to demonstrate detection and structural elucidation of metabolites from urine within a 90-second chromatographic run.

Methodology

Study design and sample preparation:

• Male beagle dogs received a single intravenous dose of paracetamol (10 mg/kg); urine was collected pre-dose and 6 hours post-dose.
• Samples underwent protein precipitation with methanol; supernatants were diluted with water and 2 μL injected for UPLC-MS analysis.

Chromatography and acquisition strategy:

• Reversed-phase UPLC using an ACQUITY UPLC HSS T3 column (1.8 μm, 2.1 × 50 mm), column temperature 40 °C, flow 0.6 mL/min.
• Final gradient gave a total runtime of 90 seconds, producing chromatographic peaks well under 1 second in width.
• To preserve data density across narrow peaks, survey scans were acquired at 50 Hz and DDA MS/MS at 100 Hz.

Automated data processing:

• Data-dependent acquisition (DDA) files were processed using MassMetaSite software for automated metabolite detection and structural assignment, minimizing manual review.

Ethics and compliance:

• Work conducted under Pharmaron UK Ltd management with adherence to internal SOPs and GLP principles where applicable.

Used Instrumentation

The key instrument and operating parameters were:

• Mass spectrometer: Xevo MRT P10 (multi-reflecting time-of-flight MS).
• Ionization: Electrospray ionization, positive mode (ESI+).
• Mass range: m/z 50–1200.
• Acquisition: Data-dependent acquisition (DDA) with survey scans at 50 Hz and MS/MS at 100 Hz.
• Source conditions: capillary 0.8 kV, cone 30 V, source temp 120 °C, desolvation temp 600 °C, cone gas 50 L/h, desolvation gas 1000 L/h.
• Transmission/tune settings: StepWave RF 150 V, body gradient 10 V, source offset 30 V.
• Lock mass: Leucine enkephalin (m/z 556.27658 and 120.08078).
• DDA specifics: Top 5 precursors, MS/MS triggered above TIC threshold 25000, +1 charge state selection, dynamic exclusion 1 s, dynamic exclusion tolerance 5 ppm; collision energy ramps applied across low/high mass ranges.

Main Results and Discussion

The workflow successfully detected and structurally annotated six paracetamol-related metabolites in urine collected 6 h post i.v. administration using a 90-second UPLC gradient. Key analytical outcomes:

• Mass accuracy: Root-mean-square (RMS) mass measurement accuracy of approximately 0.727 ppm across identified metabolites, supporting confident formula assignments.
• Throughput: Chromatographic runtime reduced from conventional 45 minutes to 90 seconds without loss of metabolite coverage.
• Acquisition performance: Survey scans at 50 Hz and MS/MS at 100 Hz provided sufficient data points across sub-second peaks to generate high-quality fragmentation spectra.
• Identified species: Parent APAP (paracetamol) and five metabolites including glucuronide and sulfate conjugates, cysteine and mercapturic conjugates, and a thiomethyl derivative. Relative abundances (area %) varied; major species included APAP-Cys, APAP-G, and APAP-S with the parent compound representing ~11% of total signal in the reported dataset.

Automated processing with MassMetaSite enabled rapid annotation, reducing operator bias and manual inspection time. The high MS/MS scan speed and resolution reduced false positives and improved confidence in both expected and unexpected metabolites. The combination of narrow chromatographic peaks and very fast acquisition required careful tuning of dynamic exclusion and intensity thresholds to balance sensitivity and redundancy in MS/MS triggering.

Benefits and Practical Applications

The integrated workflow offers several practical advantages for pharmaceutical and bioanalytical labs:

• Substantial increase in sample throughput (minutes to seconds per sample) enabling large-scale metabolism studies, ADME screening, and biotransformation profiling.
• High mass accuracy and MS/MS quality at very fast acquisition rates improve structural confidence for metabolite identification.
• Automated data mining reduces manual workload and standardizes result reporting, facilitating faster decision-making in lead optimization and safety assessment.
• Short runtimes reduce solvent and consumable usage, lowering per-sample cost and environmental footprint.

Future Trends and Possible Uses

Potential developments and applications include:

• Further integration of AI/ML algorithms for increased automation of metabolite hypothesis generation and spectral interpretation.
• Extension to multiplexed biofluid analyses (plasma, bile, feces) and direct coupling with high-throughput sample preparation robotics for fully automated pipelines.
• Application to screening of reactive or low-abundance metabolites where rapid high-resolution MS/MS improves detection confidence.
• Adoption of similar high-speed MS strategies in routine regulated environments will require robust validation protocols and harmonized data-processing standards.

Conclusions

This study demonstrates that sub-second UPLC separations combined with multi-reflecting TOF mass spectrometry and dedicated data-mining can deliver rapid, high-confidence metabolite profiling. The approach preserves structural MS/MS information despite compressed chromatographic peaks and achieves part-per-million mass accuracy, enabling automated and reliable metabolite identification within a 90-second analytical cycle. The methodology is well-suited for high-throughput ADME screening and scalable to broader metabolite discovery tasks.

References

Authors: Zamora I, Khoury-Hollins H, Fontaine F, Lock R, Pickles D, Plumb R, Wilson I. End-to-End High-Throughput Biotransformation Workflow: Automated Data Acquisition and Processing of Sub-Second UPLC Peaks Using Multi-Reflecting Time-of-Flight Mass Spectrometry and Dedicated Data-Mining Tools. Waters Corporation; 2026. Poster ID: 720009404EN.

Ethics and disclosures: Study executed by Pharmaron UK Ltd with internal ethical review and GLP-aligned procedures. Several authors are Waters Corporation employees; one author has provided consultancy services to multiple companies including Waters.